Bellicum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The com…

Biotechnology
US, Houston [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of BLCM's Analysis
CIK: 1358403 CUSIP: 079481404 ISIN: US0794814048 LEI: - UEI: -
Secondary Listings
BLCM has no secondary listings inside our databases.